Janem A, Jawabreh D, Anabseh Y, Jawabreh M, Nazzal Z, Taha A
BMC Infect Dis. 2024; 24(1):1334.
PMID: 39578776
PMC: 11583790.
DOI: 10.1186/s12879-024-10236-z.
Li Y, Ma L, Ding X, Zhang R
Front Epidemiol. 2024; 3:1304324.
PMID: 38455926
PMC: 10910981.
DOI: 10.3389/fepid.2023.1304324.
Moussa B, Hmami F, Arhoun B, El Fakir S, Massik A, Belchkar S
Cureus. 2024; 15(12):e50095.
PMID: 38186478
PMC: 10770769.
DOI: 10.7759/cureus.50095.
Sharma K, Tak V, Nag V, Bhatia P, Kothari N
Infect Prev Pract. 2023; 5(4):100312.
PMID: 37868258
PMC: 10585280.
DOI: 10.1016/j.infpip.2023.100312.
Mekonnen Y, Solomon S, Gebreyohanns A, Teklu D, Ayenew Z, Mihret A
Infect Drug Resist. 2023; 16:6345-6355.
PMID: 37789843
PMC: 10542572.
DOI: 10.2147/IDR.S418066.
Deciphering mechanisms of gene transmission between human and animals: a genomics study of bacterial isolates from various sources in China, 2015 to 2017.
Chen K, Xie M, Dong N, Chan E, Zhang R, Chen S
Euro Surveill. 2023; 28(37).
PMID: 37707983
PMC: 10687984.
DOI: 10.2807/1560-7917.ES.2023.28.37.2200925.
Epidemiology and prevention of hospital-acquired carbapenem-resistant Enterobacterales infection in hospitalized patients, Northeast Ethiopia.
Shibabaw A, Sahle Z, Metaferia Y, Atlaw A, Adenew B, Gedefie A
IJID Reg. 2023; 7:77-83.
PMID: 37009574
PMC: 10050477.
DOI: 10.1016/j.ijregi.2023.02.008.
Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors.
Herrera S, Torralbo B, Herranz S, Bernal-Maurandi J, Rubio E, Pitart C
Eur J Clin Microbiol Infect Dis. 2023; 42(5):631-638.
PMID: 36964885
DOI: 10.1007/s10096-023-04581-1.
High frequency of carbapenem-resistant Enterobacteriaceae fecal carriage among ICU hospitalized patients from Southern Iran.
Davari N, Khashei R, Pourabbas B, Nikbin V, Zand F
Iran J Basic Med Sci. 2022; 25(12):1416-1423.
PMID: 36544530
PMC: 9742572.
DOI: 10.22038/IJBMS.2022.63099.13938.
Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.
Yin C, Yang W, Lv Y, Zhao P, Wang J
BMC Microbiol. 2022; 22(1):81.
PMID: 35350977
PMC: 8962535.
DOI: 10.1186/s12866-022-02497-y.
Effectiveness of selective digestive decolonization therapy using oral gentamicin for eradication of carbapenem-resistant Enterobacteriaceae carriage.
Park S, Lee J, Oh J, Lee S, Jung J
Infect Control Hosp Epidemiol. 2022; 43(11):1580-1585.
PMID: 35135653
PMC: 9672826.
DOI: 10.1017/ice.2021.492.
Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China.
Yin L, He L, Miao J, Yang W, Wang X, Ma J
Infect Prev Pract. 2021; 3(3):100147.
PMID: 34647006
PMC: 8498732.
DOI: 10.1016/j.infpip.2021.100147.
A Recombinase Aided Amplification Assay for Rapid Detection of the Carbapenemase Gene and Its Characteristics in .
Zhang W, Feng Y, Zhao H, Yan C, Feng J, Gan L
Front Cell Infect Microbiol. 2021; 11:746325.
PMID: 34616692
PMC: 8488121.
DOI: 10.3389/fcimb.2021.746325.
Fecal Carriage and Molecular Epidemiology of Carbapenem-Resistant from Inpatient Children in a Pediatric Hospital of Shanghai.
Xu Q, Pan F, Sun Y, Wang C, Shi Y, Zhang T
Infect Drug Resist. 2020; 13:4405-4415.
PMID: 33328745
PMC: 7735787.
DOI: 10.2147/IDR.S275549.
Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait.
Al Fadhli A, Jamal W, Rotimi V
PLoS One. 2020; 15(11):e0241971.
PMID: 33201906
PMC: 7671514.
DOI: 10.1371/journal.pone.0241971.
Risk Factors for Carbapenemase-Producing Infection or Colonization in a Korean Intensive Care Unit: A Case-Control Study.
Kim Y, Lee S, Park Y, Lee Y, Yeon J, Seo Y
Antibiotics (Basel). 2020; 9(10).
PMID: 33049912
PMC: 7600752.
DOI: 10.3390/antibiotics9100680.
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
Yan L, Sun J, Xu X, Huang S
Antimicrob Resist Infect Control. 2020; 9(1):155.
PMID: 32967718
PMC: 7513325.
DOI: 10.1186/s13756-020-00816-4.
Risk Factors for Subsequential Carbapenem-Resistant Clinical Infection Among Rectal Carriers with Carbapenem-Resistant .
Chen X, Liu Q, Liu W, Yan Q
Infect Drug Resist. 2020; 13:1299-1305.
PMID: 32440167
PMC: 7211322.
DOI: 10.2147/IDR.S247101.
Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.
Vasilakopoulou A, Karakosta P, Vourli S, Tarpatzi A, Varda P, Kostoula M
Front Public Health. 2020; 8:55.
PMID: 32257988
PMC: 7093565.
DOI: 10.3389/fpubh.2020.00055.
Fecal Carriage and Epidemiology of Carbapenem-Resistant Among Hospitalized Patients in a University Hospital.
Liu Q, Liu L, Li Y, Chen X, Yan Q, Liu W
Infect Drug Resist. 2020; 12:3935-3942.
PMID: 31908504
PMC: 6929936.
DOI: 10.2147/IDR.S233795.